PLAUSIBLE CONFOUNDING FACTORS INFLUENCING ASSOCIATION OF LEFT VENTRICULAR HYPERTROPHY WITH VENTRICULAR LATE POTENTIALS IN HYPERTENSIVE PATIENTS
Abstract
Background: Ventricular late potentials (VLPs) are low amplitude, high frequency signals which are remarkable non-invasive electrocardiographic markers of myocardial tissue damage which can be used to identify ventricular arrhythmias in hypertensive patients with left ventricular hypertrophy (LVH). There are significant confounding factors which affect the association of LVH with VLPs in hypertensive patients. Noteworthy among these are gender, age, body surface area (BSA) and smoking. This study was planned to observe the effect of these confounders on VLPs in hypertensive patients with LVH. Methods: The study was conducted in Department of Cardiac Electrophysiology, Armed Forces Institute of Cardiology, Rawalpindi from Nov 2019 to Nov 2020. This was a cohort retrospective study in which 64 patients with systemic arterial hypertension on the basis of LVH were divided into two equal groups. Patients meeting inclusion criteria were selected for Signal-Averaged ECG (SAECG). Results: Out of 64 patients, 49 (76.6%) were males and 15 (23.4%) were females. The overall mean age was 60±11.80 years. To rule out the effect of probable confounders (gender, age, BSA, and smoking) which predominantly affects VLPs in hypertensive patients with LVH, logistic regression was applied. Significance of association of LVH with VLPs increased from 0.01 to 0.03 reflecting that confounder, i.e., age, gender, BSA, and smoking were actually having a negative effect on association of VLPs with LVH. Conclusion: None of the confounders were associated with VLPs reflecting negative effect on association for the two variables of interest.
Pak J Physiol 2023;19(1):3-4
References
Bacharova L. Missing link between molecular aspects of ventricular arrhythmias and QRS complex morphology in left ventricular hypertrophy. Int J Mol Sci 2019;21(1):48.
Raisi-Estabragh Z, McCracken C, Condurache D, Aung N, Vargas JD, Naderi H, et al. Left atrial structure and function are associated with cardiovascular outcomes independent of left ventricular measures: a UK Biobank CMR study. Eur Heart J Cardiovasc Imaging 2022;23(9):1191–200.
Nadarajah R, Patel P, Tayebjee MH. Is hypertensive left ventricular hypertrophy a cause of sustained ventricular arrhythmias in humans? J Hum Hypertens 2021;35(6):492–8.
Koracevic G, Stojanovic M, Lovic D, Zdravkovic M, Sakac D. Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic risk. J Hum Hypertens 2021;35(7):564–76.
Fomina IG, Dyakova TA. Left ventricular hypertrophy in arterial hypertension and arrhythmia risk. Cardiovasc Ther Prev 2022;5(8):83–9. [in Russian]
Yildiz M, Oktay AA, Stewart MH, Milani RV, Ventura HO, Lavie CJ. Left ventricular hypertrophy and hypertension. Prog Cardiovasc Dis 2020;63(1):10–21.
Banks L, Al-Mousawy S, Altaha MA, Konieczny KM, Osman W, Currie KD, et al. Cardiac remodeling in middle-aged endurance athletes: relation between signal-averaged electrocardiogram and LV mass. Am J Physiol Heart Circ Physiol 2021;320(1):H316–22.
Zorzi A, Vessella T, De Lazzari M, Cipriani A, Menegon V, Sarto G, et al. Screening young athletes for diseases at risk of sudden cardiac death: role of stress testing for ventricular arrhythmias. Eur J Prev Cardiol 2020;27(3):311–20.
Cuspidi C, Gherbesi E, Sala C, Tadic M. Sex, gender, and subclinical hypertensive organ damage —heart. J Hum Hypertens 2022:1‒8. doi: 10.1038/s41371-022-00750-5.
Giamouzis G, Dimos A, Xanthopoulos A, Skoularigis J, Triposkiadis F. Left ventricular hypertrophy and sudden cardiac death. Heart Fail Rev 2022;27(2):711–24.
Oknińska M, Paterek A, Bierła J, Czarnowska E, Mączewski M, Mackiewicz UJB, et al. Effect of age and sex on the incidence of ventricular arrhythmia in a rat model of acute ischemia. Biomed Pharmacother 2021;142:111983.
LaBounty TM, Bach DS, Bossone E, Kolias TJJ. Indexing left ventricular wall thickness to body surface area improves prognostic value. J Echocardiography 2019;36(5):824–30.
Shivkumar K. Catheter ablation of ventricular arrhythmias. N Engl J Med 2019;380(16):1555–64.
Park J, Lee HJ, Kim SK, Yi JE, Shin DG, Lee JM, et al. Smoking aggravates ventricular arrhythmic events in non-ischemic dilated cardiomyopathy associated with a late gadolinium enhancement in cardiac MRI. Sci Rep 2018;8(1):15609.
Maretta M, Simurda M, Lesko N, Gbur M, Skorvanek M, Misikova S, et al. Excessive supraventricular activity and risk of atrial fibrillation in patients with cryptogenic ischaemic stroke. Neurol Neurochir Pol 2022;56(1):75–80.
Pearman CM, Lee D, Davies B, Khan H, Tadros R, Cadrin-Tourigny J, et al. Incremental value of the signal-averaged ECG for diagnosing arrhythmogenic cardiomyopathy. Heart Rhythm 2023;20(2):224–30.
Samesima N, God EG, Kruse JCL, Leal MG, Pinho C, França FFAC, et al. Brazilian Society of Cardiology Guidelines on the Analysis and Issuance of Electrocardiographic Reports. Arq Bras Cardiol 2022;119:638–80.
Mosteller RD. Simplified calculation of body-surface area. N Eng J Med 1987;317(17):1098. doi: 10.1056/NEJM198710223171717. PMID 3657876
Li X, Guo X, Chang Y, Zhang N, Sun Y. Analysis of alterations of serum inflammatory cytokines and fibrosis makers in patients with essential hypertension and left ventricular hypertrophy and the risk factors. Am J Transl Res 2022;14(6):4097–103.
Soliman EZ, Ambrosius WT, Cushman WC, Zhang ZM, Bates JT, Neyra JA, et al. Effect of intensive blood pressure lowering on left ventricular hypertrophy in patients with hypertension: SPRINT (Systolic Blood Pressure Intervention Trial). Circulation 2017;136(5):440–50.
Caselli S, Serdoz A, Mango F, Lemme E, Vaquer Seguì A, Milan A, et al. High blood pressure response to exercise predicts future development of hypertension in young athletes. Eur Heart J 2019;40(1):62–8.
Lee JM, Chung H, Kim HO, Woo JS, Kim SJ, Kim W, et al. Ventricular late potentials measured by signal-averaged electrocardiogram in young professional soccer players. Int J Arrhythm 2021;22:3.
D’Ascenzi F, Fiorentini C, Anselmi F, Mondillo S. Left ventricular hypertrophy in athletes: How to differentiate between hypertensive heart disease and athlete’s heart. Eur J Prev Cardiol 2020;28(10):1125–33.
Downloads
Copyright (c) 2023 Pakistan Journal of Physiology
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Pakistan Journal of Physiology, Pak J Physiol, PJP is FREE for research and academic purposes. It can be freely downloaded and stored, printed, presented, cited and quoted with full reference of, and acknowledgement to the PJP.
